Principal Financial Group Inc. lowered its stake in shares of Dentsply International Inc. (NASDAQ:XRAY) by 21.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 340,265 shares of the company’s stock after selling 91,739 shares during the period. Principal Financial Group Inc. owned approximately 0.15% of Dentsply International worth $21,110,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of XRAY. Checchi Capital Advisers LLC increased its position in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock valued at $125,000 after buying an additional 41 shares during the period. Global X Management Co. LLC increased its position in Dentsply International by 110.1% in the second quarter. Global X Management Co. LLC now owns 3,169 shares of the company’s stock valued at $197,000 after buying an additional 1,661 shares during the period. Evercore Wealth Management LLC increased its position in Dentsply International by 12.6% in the second quarter. Evercore Wealth Management LLC now owns 3,204 shares of the company’s stock valued at $199,000 after buying an additional 358 shares during the period. Carnick & Kubik LLC bought a new position in Dentsply International during the first quarter valued at about $201,000. Finally, Cacti Asset Management LLC bought a new position in Dentsply International during the second quarter valued at about $203,000. Hedge funds and other institutional investors own 94.58% of the company’s stock.
Dentsply International Inc. (NASDAQ:XRAY) opened at 59.43 on Friday. Dentsply International Inc. has a 12 month low of $51.28 and a 12 month high of $65.83. The stock’s 50 day moving average price is $60.27 and its 200-day moving average price is $61.45.
Dentsply International (NASDAQ:XRAY) last posted its earnings results on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.06. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The business earned $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter last year, the firm earned $0.73 earnings per share. The company’s revenue for the quarter was up 46.4% compared to the same quarter last year. On average, equities analysts expect that Dentsply International Inc. will post $2.76 earnings per share for the current year.
The firm also recently disclosed a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be paid a dividend of $0.0775 per share. The ex-dividend date is Wednesday, September 28th. Dentsply International’s dividend payout ratio (DPR) is presently 14.49%.
Several brokerages recently weighed in on XRAY. Credit Suisse Group AG reiterated a “buy” rating on shares of Dentsply International in a report on Sunday, June 26th. Piper Jaffray Cos. reiterated a “buy” rating on shares of Dentsply International in a report on Monday, June 27th. Bank of America Corp. began coverage on shares of Dentsply International in a report on Monday, September 12th. They issued a “buy” rating and a $70.00 price target on the stock. Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a report on Wednesday, August 17th. Finally, Zacks Investment Research downgraded shares of Dentsply International from a “buy” rating to a “hold” rating in a report on Monday, August 8th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $66.82.
In other Dentsply International news, VP Rainer Berthan sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total transaction of $305,600.00. Following the completion of the sale, the vice president now owns 34,370 shares in the company, valued at approximately $2,100,694.40. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Maureen J. Macinnis sold 45,100 shares of the firm’s stock in a transaction that occurred on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total value of $2,730,805.00. Following the sale, the senior vice president now owns 36,730 shares of the company’s stock, valued at approximately $2,224,001.50. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.
About Dentsply International
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.